Fourier Transform Infrared (FTIR) spectroscopy and imaging techniques are formidable, novel, rapid and non-destructive tools for characterization of different biological systems from molecules to membranes, cells and tissues. These techniques with multivariate analysis tools can be used in the diagnosis/follow-up of diseases including cancer, and in monitoring drug or chemical induced alterations in tissues and cells. In the current study, Attenuated Total Reflectance FTIR spectroscopy together with chemometric (cluster and principal component) analysis were utilized as a diagnostic tool for urinary bladder cancer while FTIR imaging technique was used in the clarification of sodium butyrate (NaB) induced-differentiation in colon cancer cells since butyrate has an anti-proliferative effect in colon cancer. For bladder cancer studies, bladder wash samples of bladder cancer and control groups were used directly for spectra collection. ATR-FTIR studies revealed significant alterations in lipid, protein, and nucleic acid content of bladder wash samples of cancer groups as compared to the control ones. Based on these spectral variations, bladder cancer group can be successfully differentiated from control via chemometric analysis with a higher sensitivity and specificity than many other methods used currently in bladder cancer diagnosis. In colon cancer study, aggressive CaCo2 cell lines were treated with 3mM NaB and cultured for 48h for complete differentiation. Specific band ratio analysis such as lipid/protein, glycogen/phosphate and RNA/DNA were calculated from the chemical maps of control and NaB-treated cells. Imaging results indicated the reconstruction of cancer induced changes in response to NaB treatment by modulating the saturated, unsaturated, triglyceride, protein and nucleic acid content in the treated cells. The findings of this study supported that FTIR spectroscopic and imaging techniques are valuable, label-free and sensitive bio-analytical tools for cancer diagnostics and investigating the global roles of drugs on cancer treatment.